DEEMALER

This brand name is authorized in Nigeria.

Active ingredients

The drug DEEMALER contains a combination of these active pharmaceutical ingredients (APIs):

1	Artemether UNII C7D6T3H22J - ARTEMETHER
	Artemether is an antimalarial agent used to treat acute uncomplicated malaria. It is administered in combination with lumefantrine for improved efficacy. This combination therapy exerts its effects against the erythrocytic stages of Plasmodium spp. and may be used to treat infections caused by P. falciparum and unidentified Plasmodium species, including infections acquired in chloroquine-resistant areas.
	Read more about Artemether
2	Lumefantrine UNII F38R0JR742 - LUMEFANTRINE
	Read more about Lumefantrine

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-7606	Tablet	DEEMALER TABLETS(ARTEMETHER 80mg & LUMEFANTRINE 480mg) TAB 80 mg; 480 mg 1 X 6	67 RNW-PP-268622 DEEMALER TABLETS(ARTEMETHER 80mg & LUMEFANTRINE 480mg) ARTEMETHER 80MG & LUMEFANTRINE 480MG) artemether 80mg and lumefantrine 480MG. Maize Starch, Microcrystalline Cellulose, Colloidal Silicon Dioxide, PVP K-30, Isopropyl Alcohol, Purified Talc, Magnesium Stearate, Crospovidone, Methylene Chloride & Wincoat WT MP-Yellow 1101. B4-7606 Drugs Imported Products 16 Over The Counter (OTC) 6/10/2023 CUREALL IMPEX NIGERIA LIMITED, MURTALA MOHAMMED WAY KANO KANO 7013635788 cureallimpexnigerialimited@gmail.com M/S LESANTO LABORATORIES , PLOT 9,10,11 & 20, SURVEY NO 53, J.B UDYOG NAGAR, NEAR MANOR RAILWAY BRIDGE PALGHAR (EAST] MAHARASHTRA STATE INDIA, India	28/02/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
P01BF01	Artemether and lumefantrine	P Antiparasitic products, insecticides and repellents → P01 Antiprotozoals → P01B Antimalarials → P01BF Artemisinin and derivatives, combinations
Discover more medicines within P01BF01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-7606